Oxolife

Oxolife is a small-size clinical-stage company focused on female fertility.

Total raised

€4.9M

€4,900,000

Funding rounds

Investors

distinct backers

Active since

2022-12

latest 2026-02

Funding by year

EUR raised per year · 2026 YTD

High confidence

Raise-next likelihood29

base rate 45% for Grant

Exit likelihood12

base rate 12% (2+ rounds)

Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2026-02-24	Grant	€2.5M	EIC Accelerator	View deal →
2022-12-13	Grant	€2.4M	Spanish Science and Innovation Ministry	View deal →

same sector or country